PURPLE ADVOCACY, LLC for DAVITA INC.
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
End-stage renal disease reimbursement and policies related to the Medicare End Stage Renal Disease Prospective Payment System; the Affordable Care Act (Public Law 112-25); H.R. 8 - The American Taxpayer Relief Act of 2012, and subsequent rule making; S. Con. Res. 8 - Senate Budget Resolution for FY 2014; and H.J. Res 59 - Continuing Appropriations Resolution for 2014.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SARAH HAMLETT | — |
| MEGHAN JOHNSON | — |
Medicare/Medicaid MMM
End-stage renal disease reimbursement and policies related to the Medicare End Stage Renal Disease Prospective Payment System; the Affordable Care Act (Public Law 112-25); H.R. 8 - The American Taxpayer Relief Act of 2012, and subsequent rule making; S. Con. Res. 8 - Senate Budget Resolution for FY 2014; and H.J. Res 59 - Continuing Appropriations Resolution for 2014.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SARAH HAMLETT | — |
| MEGHAN JOHNSON | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.